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The effect of B27 supplement on promoting in vitro propagation of 
Her2/neu-transformed mammary tumorspheres 
 
Yiben Gu1, Jie Fu1, Pang-Kuo Lo1, Shunqi Wang1, Qian Wang2, Hexin Chen1, * 
 
1Department of Biological Sciences, 2Department of Chemistry and Biochemistry, University of South 
Carolina, Columbia, SC 29208, USA 
 
A variety of human solid tumors, including breast cancer, are considered to embrace a hierarchical organization 
in which only rare tumor-initiating cancer stem cells are truly responsible for tumor formation. Cultivation of 
tumorspheres in non-adherent conditions is widely employed for enriching these putative cancer stem cells in 
vitro. However, the absence of a defined culture medium has handicapped further characterization and isolation 
of this cell population. In this study, we used mouse mammary tumor virus MMTV-HER2/neu transgenic mice 
that mimic the HER2/Neu-positive subtype of human breast cancer as a model system, and cultured primary 
tumor cells and tumorspheres from these mice under non-adherent conditions. In addition to essential growth 
factors, we found that B27 supplement played an important role in promoting tumorsphere formation and 
maintaining cultures through passaging. A tumorsphere-formation assay and measurements of average 
tumorsphere size provided insight into the characteristics of the putative breast cancer stem cells. 
Tumorspheres were enriched for cancer stem cells through serial passaging, while sphere size was determined 
by the innate properties of cancer stem cells and independent of the culture condition. Our study identifies B27 
as an essential component of culture medium necessary for sustained propagation and enrichment of breast 
cancer stem cells in vitro. 
 
* Corresponding author: Tel: (803)777-2928; E-mail: hchen@biol.sc.edu  
 
Introduction 
 
Solid tumors account for an enormous cancer 
burden on society and represent an urgent 
therapeutic challenge. Epithelial cancers that 
derive from tissues including breast, lung, 
colon, prostate, pancreas, brain and ovary 
constitute approximately 80% of all cancers [1]. 
Breast cancer is the predominant malignancy in 
women, resulting in more than 40,000 fatalities 
annually in the United States alone and 10 
times that number worldwide [2, 3]. Breast 
cancer arises from breast tissue, most 
commonly from inner lining of lactiferous ducts 
(ductal carcinoma) or the lactating lobules 
(lobular carcinoma) [4]. Different subtypes of 
breast cancer have been identified, and survival 
rates vary greatly depending on factors such as 
genetic alterations, stage, metastastic ability 
and therapeutic resistance [5]. 
  
Approximately 25~30% of human breast 
cancers have an amplification of the Her2/neu 
gene. The Her2/neu proto-oncogene encodes a 
transmembrane tyrosine kinase receptor that is 
a member of the epidermal growth factor 
receptor (EGFR) family [5-7]. This receptor is 
normally activated by growth factors that cause 
cells proliferation and division, and switched 
“off” in the absence of such growth factors. 
Overproduction of Her2/neu protein, which acts 
a key activator of proliferative signaling 
networks, leads to uncontrolled cell 
proliferation associated with an aggressive form 
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of breast cancer [8]. Her2/neu-positive breast 
cancer tends to be particularly invasive and is 
often associated with tumor relapse, enhanced 
metastasis, induced chemotherapy resistance, 
poorer prognosis and reduced overall survival 
rates [5, 9]. Her2/neu-positive breast cancer is 
also resistant to hormonal therapy [8]. 
Monoclonal antibodies such as trastuzumab 
(Herceptin) have been used to target Her2/neu, 
usually in combination with chemotherapy, to 
improve survival rate for this patient population 
[7, 9]. However, this therapy is expensive and 
not tolerated among all patients. This demands 
prospective insights into the underlying 
mechanisms involved in Her2/neu-positive 
breast cancer, which will contribute to the 
development of improved therapies to 
eradicate this malignancy. 
 
To accomplish this goal, it is necessary to 
address the question of the cellular origins of 
solid tumors. Two major models have emerged 
over decades of cancer research. The stochastic 
model predicts that transformation is a result of 
random mutation and subsequent clonal 
selection [10]. In this model, any cell can 
accumulate neoplastic mutations and transform 
into a cancer cell, and any cancer cell has a 
similar potential for unlimited proliferation and 
tumor generation [10-12]. In contrast, the 
cancer stem cell theory views tumor as an 
aberrant organ, to which the principles of stem 
cell biology can be applied. In a similar way to 
normal tissues that are derived from somatic 
stem cells, the tumor is organized in a hierarchy 
that is initiated by tumorigenic cancer cells, or 
termed as cancer stem cells. The cancer stem 
cells acquire the capacity for extensive 
proliferation through accumulated mutations, 
and have the ability to initiate a tumor in 
immune-compromised mice that recapitulates 
the original heterogeneity of the patient tumor 
[10, 13]. A few additional properties are also 
shared by normal stem cells and cancer stem 
cells, which include the ability to migrate, the 
activation of membrane transporter activity, 
and resistance to apoptosis and chemotherapy 
[13]. The growth of cancer stem cells requires 
alterations in vital metabolic and signaling 
pathways and cell cycle progression that lead to 
the emergence of tumorigenic phenotypes [3, 
14, 15]. As suggested in this theory, normal 
stem cells are targets of mutations that convert 
normal self-renewal potential into neoplastic 
engines, and only these transformed stem cells 
are capable of launching tumor formation, and 
comprise a tiny fraction of the vast tumor mass 
[11, 15-18]. 
 
There is growing evidence revealing the 
existence of cancer stem cells in a variety of 
human cancers, including leukemia [19] and 
several solid tumors such as breast [2, 20], brain 
[21, 22], melanoma [23], prostate [24], colon 
[25, 26], pancreatic [27] and lung cancer [28]. A 
number of methods have been developed for 
identifying putative cancer stem cells. As far as 
is known, cancer stem cells resemble normal 
stem cells in their ability to grow through self-
renewal as non-adherent spherical clusters, 
known as tumorspheres, when an adherent 
substratum is not provided in the culture 
system [21, 29]. Therefore, the most widely 
used method is to grow primary tumor cells in 
serum-free non-adherent conditions, in which 
only the small fraction of tumor-initiating 
stem/progenitor cells within the tumor mass 
can survive and form tumorspheres in 
suspension [13, 20, 29]. In many cases, the 
tumorsphere can only survive for a few 
passages and gradually dies [26, 29]. In this 
study, we cultured tumorspheres from MMTV-
Her2/Neu transgenic mouse mammary tumors 
and found that addition of one supplement, 
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B27, to the culture medium, can dramatically 
increase sphere-forming efficiency and sustain 
the propagation of tumorspheres for more than 
20 passages. This finding will help to relieve the 
limitation of expanding cancer stem cells in 
vitro. 
  
Materials and Methods 
 
Isolation of cancer cells from MMTV-Neu 
transgenic mouse mammary tumors 
Spontaneous mammary tumors that developed 
from MMTV-Neu transgenic mice were 
harvested, physically separated from connective 
and fat tissues, and transferred into DMEM/F12 
medium (Gibco). Tumor tissues were minced 
into small pieces with a sterilized scalpel, and 
digested in DMEM/F12 medium with 1.5 mg/ml 
collagenase (Worthington) and 20 μg/ml 
hyaluronidase (MP Biomedicals) with agitation 
at 200 rpm for 2 hours at 37℃. The pellet was 
collected by centrifugation at 1200 rpm for 5 
min, and incubated with 0.64% NH4Cl (Stem Cell 
Technologies) for 3 min to lyse red blood cells. 
The suspension was centrifuged at 1200 rpm for 
5 min and the supernatant was discarded. The 
pellet was resuspended in DMEM/F12 medium 
and passed through a 40 μm strainer (PALL 
Corporation) to collect single cells, which were 
in turn transferred and maintained in 
Dulbecco’s modified Eagle’s medium (DMEM, 
Gibco) with 10% fetal-bovine serum (FBS, SAFC 
Biosciences) and 10 μg/ml insulin (Sigma) as 
primary tumor cells, which were named as 
parental cells. 
 
In vitro propagation of tumor-initiating 
mammospheres 
Cells harvested from spontaneous tumors were 
counted and then plated in petri dishes at a 
constant density of 40,000 viable cells per ml. 
Cells were grown in serum-free DMEM/F12 
medium (Gibco), which was supplemented with 
20 ng/ml epidermal growth factor (EGF, Sigma), 
10 ng/ml basic fibroblast growth factor (bFGF, 
Sigma), 0.4% bovine serum albumin (BSA, 
Sigma), and 5 μg/ml insulin (Sigma). 1×B27 
supplement (Gibco) was added to the 
treatment group to investigate its effect on 
tumorsphere formation. Cells were incubated in 
a humidified atmosphere with 5% CO2 at 37°C 
for 6 days, and collected by gentle 
centrifugation. The pelleted cells were 
enzymatically dissociated with accutase 
(Innovative Cell Technologies) for 10 minutes at 
room temperature, and mechanically dispersed 
by gently pipetting through a 23-gauge sterile 
needle. Single-cell suspensions were plated at 
the same density and culture conditions as 
described above, to generate the second 
generation of tumorspheres, and so forth. 
 
RNA purification and PCR amplification 
Total RNA was extracted from parental cells and 
tumorspheres using TRIzol Reagent (Invitrogen) 
according to the manufacturer’s instructions. 1 
μg of total RNA was used for the reverse 
transcription assay to generate cDNA using M-
MLV reverse transcriptase (Invitrogen). 1 μl of 
cDNA was used for a single PCR reaction to 
determine the expression levels of cell 
differentiation markers and stem cell markers. 
The following genes of interest were selected 
and tested by regular PCR: Klf4, Oct4, Sox2, 
Nanog, keratin 8, keratin 14, and keratin 18. 
 
Quantitative real-time PCR analysis 
The quantitative RT-PCR was performed using 
the fluorescent dye SYBR Green Master Mix  
(Qiagen, CA) following standard protocols on an 
ABI PRISM 7300 sequence detection system 
(Applied Biosystems, CA). The data were first 
analyzed using the Sequence Detector Software 
SDS 2.0 (Applied Biosystems). Results were 
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calculated and normalized relative to the 
GAPDH control by using the Microsoft Excel 
program. The relative expression values were 
calculated relative to GAPDH by using the 2-ΔCT 
method [40]. The data shown here represent 
the average of three independent experiments.  
  
Tumorsphere-forming efficiency assay and size 
characterization 
Tumorspheres were dissociated to single cells 
as described above, and plated in ultra-low 
attachment 96-well plate (Costar). 1000, 500, 
200, 100 and 50 cells were plated in 100μl of 
serum-free medium per well, respectively in 
triplicate. The number of spheres formed in 
each well was determined after 6 days. 
Tumorspheres from every passage were 
dissociated and assayed for tumorsphere-
forming efficiency. Meanwhile, tumorsphere 
size, defined as number of cells per sphere, was 
assessed for tumorspheres at every passage. 
 
Results 
 
Generation of mammary tumorspheres in non-
adherent conditions 
Spontaneous tumors from MMTV-Neu 
transgenic mice were dissociated to single cells 
and transferred into tissue culture flasks in 
DMEM medium with serum for cultivating 
primary tumor cells. After subculturing the cells 
for a few passages with enzymatic treatment to 
simultaneously remove fibroblasts and other 
non-tumor cells, primary tumor cells (named in 
this study as parental cells), formed an 
adherent monolayer with uniform morphology 
covering the bottom of a tissue culture flask 
(Fig. 1A). Tumor-initiating cells, as far as is 
known, resemble stem cells in their ability to 
grow through self-renewal as non-adherent 
spherical clusters, known as tumorspheres, with 
a non-adherent substratum [21, 29]. To test the 
ability of MMTV-Neu tumor cells to form 
tumorspheres, parental cells were collected and 
plated in serum-free DMEM/F12 medium that 
contained EGF, bFGF, BSA, insulin and B27 
supplement. After six days of cultutre, the 
majority of the cells died, however a small 
fraction of cells survived and formed spherical 
clusters in suspension (tumorspheres) (Fig. 1B), 
which implied the existence of putative breast 
cancer stem cells that possessed stem cell-like 
self-renewal properties. 
 
Candidate stem cell marker genes were 
overexpressed in tumorspheres 
We examined the expression levels of a few 
known molecular markers of cancer stem cells 
in tumorspheres in relative to parental cells. 
This showed that putative stem cell markers, 
such as Oct4, Sox2, Klf4, Stem Cell Antigen-1 
(Sca1) and Aldehyde dehydrogenase 1 (Aldh1) 
were overexpressed in tumorspheres, and 
differentiation markers for luminal epithelial 
cells like keratin 18 and myoepithelial cells  like 
smooth muscle actin (SMA) were 
underexpressed in tumorspheres, compared 
with parental cells (Fig. 2). The expression 
profile of these marker genes suggests the 
presence of cancer stem cell population within 
the tumorspheres at a molecular level. Note 
that cell differentiation markers were not 
always underexpressed in tumorspheres 
relative to parental cells. The reason for this 
possibly lies in the presence of cancer stem cell-
derived progeny within the tumorspheres that 
entered and stayed at various stages of 
differentiation. Stem/progenitor cells only 
constitute a tiny fraction of the heterogeneous 
cellular composition of tumorspheres. Hence 
the majority of cells at more differentiated 
stages was sufficient to give a high expression 
level of cell differentiation markers which 
almost equaled that of parental cells. 
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Figure 1. Culture of tumor cells isolated from spontaneous tumor tissues of MMTV-Her2/neu transgenic mice at different conditions. (A) 
Primary tumor cells were cultured in DMEM containing 10% FBS, exhibiting an epithelial-like morphology. (B) Mammary tumorspheres were 
grown in non-adherent suspension medium, presenting smooth-edged spherical phenotypes. Original magnification in A and B: ×100. 
 
 
 
 
 
Figure 2. Gene profiling of stem cell markers and cell differentiation markers in monolayer (ML) cells and tumorspheres (TS). (A) RT-PCR 
analysis was performed to obtain the gene expression profiles in parental cells and tumorspheres. (B) Real-time PCR was performed to evaluate 
the relative expression levels of stem cell and differentiation marker genes in parental cells and tumorspheres.  Putative stem cell markers, 
Oct4, Sox2, Klf4, Nanog, Stem Cell Antigen-1 (Sca1) and Aldehyde dehydrogenase 1 (Aldh1) were overexpressed in tumorspheres (TS), and cell 
differentiation markers, Keratin 8, Keratin 14, Keratin 18 and smooth muscle actin (SMA), were overexpressed in parental cells (ML). 
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Figure 3. Optical microscopy for tumorspheres from serial cultivation in the suspension medium with or without the presence of B27 
supplement. Morphological differences were visualized between tumorspheres maintained in two types of medium. As for +B27 medium, no 
significant morphological change was discerned over serial passaging. Original magnification: ×100. 
 
B27 supplement is crucial for serially 
maintaining tumorspheres in vitro 
Initially, we chose the simplest recipe of 
tumorsphere propagation medium containing 
only EGF and bFGF as essential growth factors 
and BSA and insulin as supplemental 
components [29, 30]. Although tumorspheres 
grew successfully in this medium for the first 
few passages, serial subcultures of 
tumorspheres eventually failed. Bubble-like 
hollow aggregates replaced normal 
tumorspheres after four or five passages, and 
repeated tests reproduced the same 
phenomenon. By comparing a large number of 
potential nutrients, we assumed that the 
addition of B27 supplement was essential and 
could replenish what was required for serial 
generation of stem cells (self-renewal) but 
missing in the previous medium [5, 20, 31-35]. 
Accordingly, tumorspheres were successfully 
maintained for more than 20 passages in B27-
containing medium. In addition, the 
morphology of tumorspheres cultured in B27-
free medium seemed to lose smoothness and 
gain roughness because of adherence of cells to 
the spherical edges during serial passaging (Fig. 
3). The strong contrast between the two culture 
conditions implied that B27 is playing an 
important role in maintaining and promoting 
tumorsphere   propagation   in   vitro.     To   test 
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Figure 4.  Tumorsphere culture of MCF7 breast cancer cells in the suspension medium with or without the presence of B27 supplement. (A) 
Morphological differences were visualized between tumorspheres maintained in two types of medium. As for +B27 medium, no significant 
morphological change was discerned over serial passaging. Original magnification: ×100. Scale bars represent 100µm. (B) Tumorsphere-forming 
efficiency assay. One hundred cells were seeded into ultra-low attachment 96-well plate. The sphere numbers are counted after 6 days. The Y 
axis shows the sphere-forming efficiency which represents the average number of tumorspheres per one hundred seeded cells. 
 
whether that B27 has the similar effects on 
sphere formation of other cells, we cultured 
another human breast cancer cell line MCF7 in 
the presence and absence of B27 supplement. 
As expected, MCF7 cells in presence of B27 
formed typical tumorsphere with higher 
efficiency (5.375% +B27 medium vs. 3.25% -B27 
medium). In contrast, cells cultured in the B27-
free medium formed atypical tumorspheres 
which were more like cell aggregates (Fig. 4).   
 
Cancer stem cells were enriched through serial 
propagation 
In order to passage tumorspheres, they were 
enzymatically and mechanically dissociated into 
a single cell suspension, and replated at a 
constant density of 40,000 viable cells per ml. 
Tumorsphere-forming efficiency was evaluated 
using an ultra-low attachment 96-well plate as 
described in materials and methods, and 
performed with tumorspheres from every 
passage in the presence and absence of B27 
supplement. In this assay, tumorsphere-forming 
efficiency reflected the percentage of cells that 
were capable of forming tumorspheres, in other 
words, the proportion of cancer stem cells. This 
experiment clearly showed that the efficiency 
of tumorsphere-formation gradually increased 
in the presence of B27 (Fig. 5). This suggested 
that over time, an increasing number of cells 
had obtained the ability to self-renew and form 
tumorspheres, reflecting an enrichment of 
cancer stem cells. However, for tumorspheres 
maintained in B27-free medium, tumorsphere-
forming efficiency rose slightly for the first 
three passages, resembling the trend observed 
in B27-containing medium, but dropped at the 
fourth generation when bubble-like aggregates 
began to replace typical spheres (Fig. 5), until 
tumorspheres were no longer observed after 
the fifth generation. This result supports our 
earlier observations that B27-free medium 
failed to maintain tumorsphere formation 
beyond  four or  five  passages.  Hence, B27 was 
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Figure 5. Tumorsphere-forming efficiency assay. Cells were seeded into ultra-low attachment 96-well plate. Five different cell densities were 
tested for +B27 and –B27 medium, respectively. Indicated numbers of the perpendicular axis showed average number of tumorspheres per well 
for a given starting cell density.  
 
essential for promoting tumorsphere-forming 
efficiency in vitro as well as maintaining serial 
propagation through which cancer stem cells 
were enriched. 
 
Tumorsphere size was dependent on the 
innate properties of cancer stem cells 
Our data showed that B27-containing medium 
supported the serial culture of tumorspheres. 
We then grew tumorspheres for multiple 
passages under these conditions and measured 
the size of individual tumorspheres, by counting 
the number of cells per tumorsphere. 
Surprisingly, the average tumorsphere size did 
not exhibit a dramatic difference over serial 
passaging (Fig. 6). We therefore concluded that 
tumorsphere phenotypes such as morphology 
and size were determined by the innate 
properties of the cancer stem cells, rather than 
the number of cancer stem cells. 
 
Discussions 
 
The cancer stem cell hypothesis was proposed 
to resolve the question of cellular origins of 
malignancy, and to explain the observation that 
only a small proportion of cells within a tumor 
were tumorigenic [1, 10, 16]. Cancer stem cells, 
representing only a small fraction of cells within 
the bulk of tumor, have properties that render 
them capable of initiating a tumor, in contrast 
to the non-tumorigenic majority of cells [10, 15, 
18]. Although cancer stem cells have not yet 
been isolated and fully characterized, there is a 
body of growing evidence revealing the 
existence of this population in a variety of 
human cancers [19-28]. The investigation and 
characterization of cancer stem cells has 
important implications for understanding 
cancer biology and in the development of 
efficient therapies [13, 20]. 
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Figure 6. Characterization of average tumorsphere size. The tumorspheres cultured in +B27 and –B27 medium were collected and dissociated 
for size evaluation. The range of average size was 170~193 cells per sphere. 
 
When primary cancer cells from the mouse 
mammary tumors in our study were cultivated 
on a solid substratum in the presence of serum-
containing medium, cell underwent 
differentiation induced by environmental 
stimuli. A suitable system was urgently needed 
to maintain the cancer stem cells in an 
undifferentiated state, to allow serial passaging 
and propagation in culture. As cancer stem cells 
were speculated to resemble their non-mutated 
counterparts in the ability of forming spheres in 
non-adherent serum-free condition, a 
prospective method of propagating/enriching 
solid cancer stem cells in vitro was developed 
[5]. Major advances were achieved when an 
undifferentiated population of neural cells 
could be grown in suspension without losing 
multipotential differentiation capacity, and 
these cells formed non-adherent spherical 
clusters, termed as neurospheres, and 
contained 4~20% of stem cells [36, 37]. This 
method was instrumental in cancer stem cell 
research for various human malignancies, and 
was also employed in the study of breast cancer 
[2, 20, 29]. We adopted the same method, and 
have successfully grown tumorspheres from 
primary tumor cells in an anchorage-
independent suspension in the presence of 
suitable growth factors (EGF and bFGF). At the 
molecular level, putative stem cell markers 
were overexpressed in these mammary 
tumorspheres, showing a molecular signature 
of their stem cell-like properties.  
 
However, the absence of suitable defined 
systems to maintain cells in the 
undifferentiated state impeded further progress 
in the isolation and characterization of the 
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cancer stem cells, rendering this population 
elusive [13, 20, 38]. It is important to initially 
establish a reliable in vitro system of 
maintaining the scarce cancer stem cells. In our 
study of HER2/Neu-transformed breast cancer 
stem cells, we found the powerful effect of B27 
supplement in promoting tumorsphere 
formation and maintaining serial propagation, 
compared with the B27-free medium. The 
advantage of B27 supplement was clearly 
apparent. Firstly, serial cultures of 
tumorspheres were achieved, allowing for a 
constant source of tumorspheres for the long-
term study of breast cancer stem cells, owing to 
the role of B27 in increased survival of 
tumorspheres [20, 34, 39] and prevention of 
adherences [35]. Secondly, a tumorsphere-
forming efficiency assay exhibited the role of 
B27 supplement in improving the tumorsphere-
forming efficiency over serial passaging. 
Assessment of tumorsphere-forming efficiency 
revealed the enrichment of the cells capable of 
self-renewing and forming tumorspheres. The 
high productivity of “higher” passages of 
tumorspheres helps to save time and the 
investment in expensive tumorsphere 
cultivation.  One of the potential pitfalls is that 
the tumorspheres are heterogeneous in nature. 
Despite the increase in sphere-forming 
efficiency, only a relatively small percentage of 
cells with each sphere hold the sphere-forming 
capacity. In addition, not all sphere-forming 
cells fulfill the criteria of being cancer stem 
cells.  The heterogeneity of tumorsphere in 
cellular origin and composition makes it 
possible that the percentage of cancer stem 
cells may decrease after extended numbers of 
passages in vitro, e.g. the cancer stem cells may 
be outnumbered by cancer progenitor cells with 
capacity to form sphere. But the total cancer 
stem cells population will expand through self 
renewal with continuously passaging of 
tumorspheres. Lastly, B27 also seemed to be 
favorable in preserving adequate viability of 
frozen tumorspheres. Tumorspheres stored at -
80ºC freezer showed a higher recovery rate in 
freezing medium that contained B27 
supplement (data not shown). Despite the 
unknown effects of diverse components, B27 
supplement, it is clearly an essential part of the 
culture medium necessary for sustained in vitro 
tumorsphere propagation and the study of 
cancer stem cells. 
 
Conclusions 
 
We grew primary tumor cells and tumorspheres 
out of mammary tumor tissue harvested from 
MMTV-Neu transgenic mice. In the process of 
characterization of mammary tumorspheres, 
we found that B27 supplement, in addition to 
essential growth factors, played an important 
role in promoting tumorsphere formation and 
sustaining serial cultures, compared with the 
counterparts maintained in B27-free medium. A 
tumorsphere-formation assay revealed the 
enrichment of breast cancer stem cells in vitro 
through serial passaging. The average 
tumorsphere size was, however, independent 
of the culture condition and inferred to be 
determined only by the innate properties of 
cancer stem cells. Yet the mechanism remains 
unknown, our study identifies that B27 
supplement is necessary for sustained 
propagation and enrichment of breast cancer 
stem cells in vitro. 
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